MS
Mark E Saad (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $6.2M of AXSM (37,577 sh across 2 lots, as filed), executed Dec 31 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.2M
shares × price, as filed
Last traded
Dec 31 2025
Filed Jan 2
Median ADV $188.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
AXSMRecent filings
AXSMSALE
Axsome Therapeutics, Inc.
View filing →
$6.2M37,577 sh across 2 lots
Exec Dec 31 2025
Filed Jan 2 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $1.1M
9,127 sh × $125.07
Exec Sep 5 2025
Filed Sep 5 2025 · 5:30 PM ET